Premas Biotech and Oramed announce oral COVID-19 vaccine candidate that produces antibodies after a single dose

Must Read

Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral COVID-19 vaccine that has shown efficacy after a single dose, in conjunction with Oramed Pharmaceuticals Inc. …

Latest News

RI targets migrant worker agreement with Portugal by late November

Jakarta (ANTARA) - Indonesia and Portugal are finalizing a Memorandum of Understanding (MoU) aimed at expanding employment opportunities and...

More Articles Like This